Company & Sponsor Intelligence
Centre Hospitalier Universitaire de Saint Etienne
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed2
Countries1
Therapeutic footprint
alzheimersparkinsonsstroke
Indexed studies
NCT03249844Paediatric Arteriopathy Steroid Aspirin Project
stroke · PHASE3
stroke · PHASE3
NCT02670993Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's Disease
alzheimers · FranceNA
alzheimers · FranceNA
NCT03342339Influence of Emotions on Decision-making in Parkinson's Disease
parkinsons · FranceNA
parkinsons · FranceNA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →